Booth No: N226
GlycoNex specializes in the development of antibody-based therapeutics and glycan-directed cancer therapies. With 20 years experiences, GlycoNex has developed a comprehensive platform for antibody development, covering antibody engineering, stable cell line development, analytical development all the way to the 50L-production. Based on this platform, GlycoNex has created different types of products including innovative antibodies, anti-glycan antibody bank, biosimilars, and Fc-fusion protein.
Exhibitors you may be interested in